Daiwa Securities Upgrades Merck (MRK) to Outperform (2)

Daiwa Securities analyst Narumi Nakagiri upgraded Merck (NYSE: MRK) from Neutral (3) to Outperform (2) with a price target of $143.00 (from $120.00).

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $130.42 yesterday.

You May Also Be Interested In

• Citi Upgrades a2 Milk Co (A2M:AU) (ACOPF) to Buy
• JPMorgan Double Upgrades Hemnet Group AB (HEM:SS) to Overweight
• Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral